Should I Get Screened for Sleeping Sickness? A Qualitative Study in Kasai Province, Democratic Republic of Congo

Abstract

BackgroundControl of human African trypanosomiasis (sleeping sickness) in the Democratic Republic of Congo is based on mass population active screening by mobile teams. Although generally considered a successful strategy, the community participation rates in these screening activities and ensuing treatment remain low in the Kasai-Oriental province. A better understanding of the reasons behind this observation is necessary to improve regional control activities.MethodsThirteen focus group discussions were held in five health zones of the Kasai-Oriental province to gain insights in the regional perceptions regarding sleeping sickness and the national control programme's activities.Principal FindingsSleeping sickness is well known among the population and is considered a serious and life-threatening disease. The disease is acknowledged to have severe implications for the individual (e.g., persistence of manic periods and trembling hands, even after treatment), at the family level (e.g., income loss, conflicts, separations) and for communities (e.g., disruption of community life and activities). Several important barriers to screening and treatment were identified. Fear of drug toxicity, lack of confidentiality during screening procedures, financial barriers and a lack of communication between the mobile teams and local communities were described. Additionally, a number of regionally accepted prohibitions related to sleeping sickness treatment were described that were found to be a strong impediment to disease screening and treatment. These prohibitions, which do not seem to have a rational basis, have far-reaching socio-economic repercussions and severely restrict the participation in day-to-day life.Conclusions/SignificanceA mobile screening calendar more adapted to the local conditions with more respect for privacy, the use of less toxic drugs, and a better understanding of the origin as well as better communication about the prohibitions related to treatment would facilitate higher participation rates among the Kasai-Oriental population in sleeping sickness screening and treatment activities organized by the national HAT control programme.

Epidemiology of human African trypanosomiasis

“…HAT is also a stigmatizing disease, mainly because of the neuropsychological impairment entailed, and in many endemic areas, the presence of the disease is hidden and the patients are discriminated or abandoned 79,123…”

The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei

“…Although new cases of HAT have fallen to below 7,000 in 2011, the disease carries a major risk of resurgence with epidemiological population shifts, climate change, and civil unrest (1, 6). The disease is a key factor in maintaining the poverty cycle in neglected communities, and it is also a stigmatizing disease causing neuropsychological impairment and abandonment for its suffers (7, 8). In 2012, the World Health Organization targeted elimination of T. brucei gambiense HAT (which accounts for 98% of HAT cases) by 2020 (9).…”

Barcoding in trypanosomes

“…A lack of formal training for front-line medical workers, local stigma surrounding diagnosis of sleeping sickness and a delay in patients contacting medical services only exacerbates the problem of surveillance and monitoring of this disease (Mpanya et al 2012;Acup et al 2016). When an infected kissing bug takes a blood meal, T. cruzi is passed out in the insect's feces and is typically deposited near the bite wound.…”